| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Siglec-15 | HOT SG5-H52H3 | Human Siglec-15 / CD33L3 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $415.00 100ug | ||
| Siglec-15 | HOTAvitag SG5-H82F5 | Biotinylated Human Siglec-15 / CD33L3 Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| Siglec-15 | HOT SG5-H5253 | Human Siglec-15 / CD33L3 Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $415.00 100ug | ||
| Siglec-15 | HOTAvitag SG5-H82E9 | Biotinylated Human Siglec-15 / CD33L3 Protein, His,Avitag™ (recommended for biopanning) | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| Siglec-15 | Rhesus macaque Siglec-15 / CD33L3 Protein, His Tag | Rhesus macaque | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | |||
| Siglec-15 | Mouse Siglec-15 / CD33L3 Protein, His Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | |||
| Siglec-15 | Rat Siglec-15 / CD33L3 Protein, His Tag (MALS verified) | Rat | HEK293 | ![]() | MALSSDS-PAGE | $360.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| NC-318 | NC-318; 5G-12 | Phase 2 Clinical | Yale School Of Medicine | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Endometrial Neoplasms; Lung Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | Details |
| DS-1501 | DS-1501 | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Osteoporosis | Details |
| BSI-060T | PYX-106; BSI-060T | Phase 1 Clinical | Biosion Inc | Neoplasm Metastasis; Solid tumours | Details |


